Centessa Pharmaceuticals PLC Stock Ownership - Who owns Centessa Pharmaceuticals?

Insider buying vs selling

Have Centessa Pharmaceuticals PLC insiders been buying or selling?
Antoine YverEVP Chairman of Development2023-06-016,500$4.45
Tia L. BushChief Quality Officer2023-05-243,000$4.48
Tia L. BushChief Quality Officer2023-05-245,000$4.49
Antoine YverEVP Chairman of Development2023-05-016,800$4.42
Antoine YverEVP Chairman of Development2023-04-036,700$3.69
David J. GraingerChief Innovation Officer2023-03-314,825$3.90
David M. ChaoChief Administrative Officer2023-03-316,969$3.90
Antoine YverEVP Chairman of Development2023-03-313,615$3.90
Thomas TemplemanChief Technology Officer2023-03-314,103$3.90
Saurabh SahaChief Executive Officer2023-03-3122,013$3.90

1 of 6

CNTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTA insiders and whales buy or sell their stock.

CNTA Shareholders

What type of owners hold Centessa Pharmaceuticals PLC stock?
Medicxi Ventures Management Jersey Ltd20.98%19,963,157$89.83MInstitution
General Atlantic LP10.17%9,681,818$43.57MInstitution
Gap Bermuda Ltd10.17%9,681,818$43.57MInsider
Bvf Inc9.90%9,423,215$42.40MInstitution
Ecor1 Capital LLC5.90%5,618,779$25.28MInstitution
Vida Ventures Advisors LLC4.13%3,931,818$17.69MInstitution
Oup Management Co LLC3.09%2,937,615$13.22MInstitution
Price T Rowe Associates Inc2.43%2,313,433$10.41MInstitution
Point72 Asset Management LP1.87%1,775,482$7.99MInstitution
Samsara Biocapital LLC1.78%1,693,736$7.62MInstitution

1 of 3

CNTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTA70.29%14.96%Net SellingNet Selling
WVE62.03%37.97%Net Buying
ALVR14.07%85.93%Net BuyingNet Selling
OMGA57.74%42.26%Net BuyingNet Selling

Centessa Pharmaceuticals Stock Ownership FAQ

Who owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals (NASDAQ: CNTA) is owned by 70.29% institutional shareholders, 14.96% Centessa Pharmaceuticals insiders, and 14.75% retail investors. Gap Bermuda Ltd is the largest individual Centessa Pharmaceuticals shareholder, owning 9.68M shares representing 10.17% of the company. Gap Bermuda Ltd's Centessa Pharmaceuticals shares are currently valued at $43.18M.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.